We previously showed that Rab31 overexpression attenuates invasion and enhances proliferation of breast cancer cells through inhibition of the EMT-like phenotype and the switch to the more proliferative MET-like phenotype (Grismayer et al. 2012). Here, RAB31 is linked to breast carcinoma.